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Abstract
Purpose: Contemporary approaches to clinical diagnosis have not adequately exploited state-of-the-art empirical
techniques in deriving diagnostic criterion sets that are statistically optimal based on 1) relevant external indicators
and 2) replicability across data sets. We provide a proof of concept that optimal criterion sets can be derived with
respect to alcohol use disorder (AUD) diagnosis that are both more efficient and precise than current systems.
Methods: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions we selected
chronicity (i.e. persistence) of AUD diagnosis and comorbidity of AUD with other disorders as validation criteria on
which to optimize the size of the AUD criterion set and the threshold for AUD diagnosis. We used cross-validation
and consensus approaches for choosing a final solution.
Results: Cross-validation did not produce a solution that replicated across random subsamples or differed from
conventional diagnosis. Alternatively, consensus produced a more global solution that was associated with greater
validity than “conventional” diagnosis.
Conclusion: Such methods, if applied to extant diagnostic criteria and algorithms can generate simpler and more
reliable rules and hold promise for greatly reducing misclassification of individuals in both research and applied
clinical contexts.
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Background
Much of the foundational structure of clinical practice,
psychiatric epidemiology, etiological research in psycho-
pathology, and other research enterprises related to men-
tal illness is based on psychiatric diagnosis. Progress in all
of these areas requires a valid structure for classifying and
quantifying psychiatric symptomatology. The modern
diagnostic approach, first formalized by Kraepelin (1883),
argued that distinct disorders could be characterized by
careful syndromal observation coupled with course
(i.e., diagnosis by prognosis). Approaches to determining
how psychiatric syndromes should be carved out from the
universe of symptoms have not advanced greatly since the
modern diagnostic era began. Although there have been a
number of important discoveries in the area of psycho-
pathology, the arguably slow progress of scientific research
in psychopathology compared to many other health-re-
lated conditions is almost certainly attributable, in
part, to limitations of the existing psychiatric nosology,
currently exemplified, but certainly not limited to, the
Diagnostic and Statistical Manual of Mental Disorders,
fourth edition (DSM-IV; American Psychiatric Association
2000) and fifth edition (DSM-5; American Psychiatric
Association 2013).
As a result, traditional diagnostic approaches have been
criticized in recent years, and alternatives focusing on
more transdiagnostic, process-based constructs that repre-
sent specific underlying mechanisms of mental disorders
in general, such as the Research Domain Criteria (RDoC;
e.g. Insel et al., 2010), and addictive disorders specifically
(Litten et al., 2015), have been proposed. We are sympa-
thetic to the RDoC approach but believe that there are
numerous methodological and conceptual challenges (e.g.
Miller & Rockstroh, 2013) and that the field is far from
implementation in the clinic on even some of the most
“tried and true” RDoC measures (see Sher, 2015).
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Therefore, we believe that improved clinical diagnosis
using extant frameworks will play an important role in
advancing the field for the foreseeable future. Further-
more, the types of optimization analyses that we propose
have considerable promise for parallel application within
an RDoC framework, in which diagnostic criteria are
replaced with transdiagnostic psychological dimensions.
In the current paper, we adopt a novel approach,
enabled by recent developments in quantitative and
behavioral sciences, to empirically derive new optimal
diagnostic criteria sets and algorithms for alcohol use
disorder (AUD). This research is motivated by the fact
that contemporary approaches to diagnosis have not ad-
equately exploited empirical techniques to derive criteria
that could be considered optimal with respect to predict-
ing relevant external criteria robustly and showing
generalizability across data sets and populations. Indeed,
the predominant approach for developing diagnostic cri-
teria sets has been to convene expert panels to draft
criteria sets informed by systematic literature reviews,
with additional but limited reanalysis in some instances,
and then to characterize the performance of these
criteria sets with respect to traditional psychometric
properties (e.g., factor structure and test-retest stability;
Hasin et al., 2012) and clinical considerations (e.g., ease
of use, estimated prevalences; see Hasin et al., 2013).
It is critical to note that DSM-5 and its predecessors
(American Psychiatric Association, 1980, 2000, 2013), as
well as the International Classification of Diseases and
Related Health Problems (ICD-10) and its precursors
(World Health Organization, 1977, 1978, 1992) were de-
veloped primarily for clinical practice and public health
efforts. The research community was not a primary
constituency in the development of diagnostic criteria.
Indeed, both DSM and ICD systems of classification
were developed emphasizing clinical utility over research
utility. Additionally, both the APA and WHO have
stressed that future iterations of these diagnostic systems
should be implementable and enhance usability for the
clinicians for whom they were designed (Kendler et al.,
2009; Reed, 2010). Empirically derived optimal criterion
sets using the existing classification systems have the very
real potential to reduce the number of criteria clinicians
need to consider when diagnosing clients, significantly
reducing the burden of diagnosis on clinicians while at the
same time increasing diagnostic validity.
Furthermore, although the DSM and ICD were devel-
oped primarily to serve clinical efforts, these systems have
become the standard for making diagnoses across many, if
not most, psychiatric disorders in research contexts. This is
unfortunate because diagnoses derived from the DSM/ICD
have never been shown to be optimal for characterizing
conditions of interest. The cost of having criteria sets that
are suboptimal could be immense and result in increased
rates of both Type 1 (i.e., “false discoveries”) and Type 2 er-
rors (i.e., false negative findings) in research contexts and,
similarly, suboptimal diagnosis in clinical settings.
We seek to provide a proof of concept that optimal
criterion sets can be derived, based on a small set of
user-specified (or otherwise agreed-upon) assumptions,
for AUD diagnosis. We chose AUD among the existing
predefined set of disorders for a number of reasons. First it
belongs to the broader group of substance use disorders
(SUDs), all of which make use of a relatively simple count
of endorsed criteria to determine diagnosis. This is in con-
trast to other disorders which sometimes structure criteria
sets hierarchically (e.g. depressive and bipolar I disorders;
c.f. Lane & Sher, 2014). Thus, SUDs constitute a relatively
simple and concrete structure for diagnosis that can be lev-
eraged as a first test or whether criterion set optimization
can be realistically operationalized. Second, as described
below, there are a number of reasons to question the accur-
acy and efficiency of AUD diagnosis and its criterion set.
For example, test-retest reliability for AUD in field tri-
als of the purportedly improved DSM-5 (over DSM-IV)
has not been impressive (Regier et al., 2013; Freedman
et al., 2013), though design issues may be partially re-
sponsible. However, unreliability may also come from
findings that indicate that some criteria are mild or nor-
mative (Tolerance), not necessarily indicative of path-
ology (Hazardous Use), or easily misunderstood (Larger/
Longer; see Martin et al., 2011a). As a result, some re-
searchers have suggested that the 2-of-11 rule, in refer-
ence to the number of criteria that need to be endorsed
in order to qualify for diagnosis, will diagnose many
whose substance involvement has questionable clinical
significance (Martin et al., 2011b). Furthermore, there
has been evidence suggesting that the 2/11 rule results
in substantial overlap in presumed latent severity be-
tween those who are subsyndromal (i.e., 1/11 criteria
met) and those at diagnostic threshold (Lane & Sher,
2014). This overlap is also observed at higher levels of
syndromal severity and is suggestive of nonadditivity of
the criteria when endorsed in different combinations,
which could be due to predictive redundancy across cri-
teria or because some criteria are particularly fallible by
themselves but are internally validated by the presence
of some specific, additional criteria (Lane & Sher, 2014).
In the following example we use data from a large na-
tionally representative sample of United States residents
to demonstrate the feasibility and utility of extracting
optimal criterion sets for diagnosing AUD. We use (1)
chronicity of an AUD diagnosis from baseline to fol-
low-up and (2) comorbidity of other Axis I and Axis II
disorders (also assessed at baseline) with an AUD diagno-
sis, as objective criteria with which to optimize diagnosis.
Chronicity was chosen as one primary consideration
given its recognized importance since the time of Kraepelin
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(see also Spitzer, 1983). Comorbidity (co-occurrence) with
other disorders (Grant et al., 2005, 2006) was chosen
as many psychometric studies have demonstrated
that these disorders are associated with not only ex-
ternalizing psychopathology (Krueger et al., 2007) but
overall psychopathology more generally (Caspi et al., 2014),
and it is consistent with the notion of a condition being as-
sociated with harm (Spitzer, 1999; Wakefield, 1992). We
note that there are a number of alternative criteria (e.g.,
level of consumption, physical health, general psychosocial
functioning) that could be used for optimization, but con-
tend that these two domains provide a clinically meaning-
ful set of criteria in that they leverage both chronicity and
clinically meaningful psychopathology to identify symptom




The National Epidemiological Survey on Alcoholism and
Related Conditions (NESARC; Grant et al., 2003b; Grant
et al., 2005) is a nationally representative sample of non-
institutionalized United States civilians 18 years and older.
The survey oversampled minority ethnicities (Blacks and
Hispanics) and young adults between the ages of 18 and
24. The initial wave, which was administered using face-
to-face interviews between 2001 and 2002 contained
43,093 respondents (Grant et al., 2003b). A second follow-
up wave of assessment was conducted during 2004-2005
and contained 34,653 of the same respondents (Grant &
Kaplan, 2005). The instruments used to assess disorders
in both waves of the NESARC followed DSM-IV Ameri-
can Psychiatric Association (2000) specifications. Though
Wave 2 did include criterion items assessing craving,
which has since been added to the DSM-5 AUD criterion
set (American Psychiatric Association 2013), its absence
at Wave 1 precluded a precise estimate of DSM-5 AUD
chronicity. Given that chronicity is a central validity indi-
cator in the current study, we instead used the 11 DSM-
IV AUD criteria (10 of which overlap with DSM-5), since
they were fully assessed at both waves.
In the current analyses we limit our sample to the 15,773
individuals (male = 7,428 [47 %], female = 8,345 [53 %]) in
Waves 1 and 2 who had consumed at least one alcoholic
beverage in the past year and also did not exhibit missing
data on any of the items used in the optimization procedure
(e.g., all of the AUD criteria and the Axis I and Axis II co-
morbidity items). We did so because individuals who
abstained from drinking would contribute little to no vari-
ance to both AUD criteria endorsement and the drinking-
related validity measures. Individuals ranged in age from
20 to 90 years (M = 44.2, SD = 15.7), with a majority White
(65.8 %) and the remainder Hispanic (16.0 %), Black
(14.7 %), Asian (2.0 %), and Native American (1.5 %).




The 11 criteria used to diagnose the presence and severity
of AUD include 1) increased tolerance to alcohol’s effects
(Tolerance), 2) attempts to cut down or control use (Cut
Down), 3) drinking larger amounts or for longer periods of
time than intended (Larger/Longer), 4) giving up important
social, occupational, or recreational activities (Give Up), 5)
spending a lot of time obtaining, using, or recovering (Time
Drinking), 6) continued use despite physical or psychological
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≥ 65 1,971 12.5
Marital status
Married or cohabiting 9,038 57.3
Widowed, separated, or divorced 3,387 21.5
Never married 3,351 21.2
Educational level
Less than high school 1,049 9.6
High School 4,139 26.2
Some college or higher 10,125 64.2
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problems (Continue), 7) experiencing withdrawal symptoms
(Withdrawal), 8) failure to fulfill role obligations (Home/
Job), 9) using alcohol in physically hazardous situations
(Hazardous Use), 10) getting arrested, held at a police sta-
tion, or having other legal problems (Legal), and 11) contin-
ued use despite social and interpersonal problems (Fight/
Trouble). Using DSM-IV guidelines (American Psychiatric
Association 2000) for criterion endorsement each criterion
was coded as present (‘1’) or absent (‘0’) in the past year
based on individuals’ responses to the particular criterion
items using the Alcohol Use Disorder and Associated Dis-
abilities Interview Schedule-IV (AUDADIS-IV; Grant et al.
2003a). Using past year endorsement was critical for
strictly defining chronicity in the current example such
that endorsement could be mutually exclusive and assess-
ment timeframes and associated endorsement rates would
be comparable at each wave. Endorsement rates for each
criterion at both waves are shown in Table 2. In addition,
we also included endorsement of the craving criterion from
Wave 2 as an external validation measure for comparisons
between DSM-IV and our optimally derived diagnoses.
Axis I and Axis II diagnoses
Presence of lifetime Axis I (AxI) and Axis II (AxII) diagno-
ses (i.e. non-AUD/SUD) was assessed using responses
from Wave 1 and Wave 2. The same eleven Axis I disor-
ders were assessed in both the first and second waves of
the NESARC; however, we focused on seven based on
their high comorbidity with AUD (Major depressive epi-
sode, Dysthymia, Hypomanic episode, Panic disorder with
or without agoraphobia, Social phobia, Specific phobia
[though more equivocally], Generalized anxiety disorder;
Sher et al., 2014). We used the lifetime diagnosis of these
seven disorders as of Wave 1 as comorbidity criteria on
which to derive optimal solutions and then used the same
(cumulative) lifetime measures as of Wave 2 as external
validation criteria on which to compare our optimal diag-
nostic solution with diagnoses generated by DSM-IV.
Seven Axis II disorders were assessed at Wave 1
(Avoidant, Dependent, Paranoid, Obsessive-Compulsive,
Schizoid, Histrionic, and Antisocial). In contrast, only three
PDs were assessed at Wave 2 (Borderline, Schizotypal, Nar-
cissistic). For Antisocial PD, Wave 1 included the assess-
ment of Conduct Disorder before age 15 and Adult
Antisocial Behavior at or after age 15, whereas Wave 2 in-
cluded only an assessment of Adult Antisocial Behavior
since the last interview.
For Axis II disorders, we used lifetime diagnoses across
Wave 1 and Wave 2 to facilitate aggregation given the un-
balanced design. This involved using lifetime measures of
the three Axis II disorders assessed at Wave 2, the lifetime
measures of the six Axis II disorders assessed at Wave 1
(acknowledging the limitation that individuals could have
developed these disorders after Wave 1), and an inclusive
combination of individuals who qualified for either Wave
1 lifetime Antisocial PD or both Wave 2 Adult Antisocial
Behavior and Wave 1 pre-age-15 Conduct Disorder. Pres-
ence/absence of each disorder was coded as present (‘1’)
or absent (‘0’) and aggregated as detailed below.
Health indices
The ten subscale measures from the SF12-V2 Physical
and Mental Functioning scales (Ware et al., 2002) were
used as external validators for the optimization proced-
ure. These included measures of physical health, mental
health, a physical health subscale, role physical health,
bodily pain, general health, vitality, social health, role
emotional health, and a mental health subscale. Each
scale was originally constructed to have a mean of 50
and a standard deviation of 10.
Drinking behavior
Individuals’ self-reported drinking behavior was operation-
alized with two survey questions. The first was a survey-de-
rived measure of average daily volume of ethanol
consumption in the last 12 months based on individuals’ re-
ports of the quantity and frequency with which they drank.
The second was the number of times an individual reported
exceeding daily drinking limits (5+ drinks in a 2-h window
for men, 4+ for women; Grant et al., 2003a, 2003b).
Optimization approach
When considering how to choose a relevant diagnostic
rule, persistence and two types of comorbidity were con-
sidered. Persistence is defined as the conditional prob-
ability that if a person is diagnosed at Wave 1 what is
the probability he/she is diagnosed at Wave 2, given as
P(AUD2|AUD1) in the equations presented below; natur-
ally, 0 ≤ P(AUD2|AUD1) ≤ 1. The two types of comorbid-
ity considered were the comorbidity between diagnosis
of AUD at Wave 1 and a diagnosis of Axis I symptom
disorders (AxI), denoted as C(AUD1, AxI), and the
Table 2 DSM-IV endorsement percentages for Waves 1 and 2
Criterion % Endorse Wave 1 % Endorse Wave 2
Larger/Longer 8.9952 11.6940
Cut Down 8.1693 10.9700








Give Up .6643 .7421
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comorbidity between a diagnosis of AUD at Wave 1 and
a diagnosis of Axis II personality disorders (AxII), de-
noted as C(AUD1, AxII). Here, diagnosis of AUD (i.e.
AUD1 and AUD2), which implicitly contains both the
set of specific criteria used for diagnosis and the thresh-
old of number of criteria required for diagnosis, is the
variable being optimized, and is thus a priori, not well
defined. We are agnostic to the optimal solution and so
include the entire criterion set of 11 DSM-IV criteria
and all possible threshold values as candidates.
The first consideration is how to appropriately measure the
comorbidity between a diagnosis of AUD and an Axis I or
Axis II disorder. For all variables considered, the diagnosis is a
binary outcome where a “1” and “0” indicate diagnosis and no
diagnosis, respectively. Two binary variables result in the pos-
sibility of four logical states: (a) a diagnosis on both variables,
(b) a diagnosis on the first variable but not the second, (c) a
diagnosis on the second variable but not the first, and (d) no
diagnosis on either variable. For each of the four conditions,
we will let a, b, c, and d represent the total number of individ-
uals within each condition, respectively. Based on these four
values several various measures of agreement can be con-
structed (e.g., correlation, Yule's Q, Yule's Y, odds ratio, etc.).
For the current optimization task, we utilize Jaccard's
measure (1901), defined as a/(a + b + c). Jaccard's measure
has the advantage of ignoring d, the mutual absence of a
trait (e.g., no diagnosis on each variable), which is neces-
sary in situations where the overall prevalence of several
variables can be comparatively small (e.g., not close to .5)
as with many disorders (Grant et al., 2005, 2006; Kessler
et al., 2005). Including d in these instances can artificially
increase or decrease the similarity measure due to the high
value of d by design. We denote J(V1,V2) as the agreement
between variables V1 and V2; clearly, 0 ≤ J(V1,V2) ≤ 1.
Given a choice of agreement measure, the question
becomes how to measure the agreement between a
single diagnosis of AUD and a construct, such as Axis I
symptom disorders, which contains several individual
variables. Comorbidity between AUD at Wave 1 and Axis
I symptom disorders is defined as,
C AUD; AxIð Þ ¼ med J AUD1;Major Depressionð Þ;
J AUD1;Dysthymiað Þ;
J AUD1;Hypomanicð Þ;
J AUD1;Panic w= or w=o Agoraphobiað Þ;
J AUD1; Social Phobiað Þ;
J AUD1; Specific Phobiað Þ;






where “med” denotes the median. Similarly, comorbidity
between AUD1 and Axis II personality disorders is
constructed from the individual comorbidities between
AUD1 and the three personality disorder clusters of Axis
II; Cluster A (CA), Cluster B (CB), and Cluster C (CC)
subgroups as
C AUD1; AxIIð Þ ¼ :1C AUD1; CAð Þ
þ :7C AUD1; CBð Þ
þ :2C AUD1; CCð Þ ð2Þ
where,
C AUD1; CAð Þ ¼ med J AUD1;Paranoidð Þ;
J AUD1; Schizoidð Þ;




















The general weighting scheme was based on the obser-
vation that so-called Cluster B personality disorders
(esp. Antisocial and Borderline) are likely to be more
highly comorbidity than Cluster A (Odd/eccentric) and
Cluster C (anxious/fearful) but with a tendency for Clus-
ter C to be slightly more associated with AUD than
Cluster A and that this general ordering is consistent
with the larger personality literature on AUD correlates
(Sher et al. 2005; Sher et al., 1999). The general ap-
proach is to change the rule (e.g., algorithm) which de-
termines diagnosis of AUD and compute C(AUD1,AxI),
C(AUD1,AxII), and P(AUD2|AUD1) for each of the dif-
ferent scenarios. For the eleven criteria that are included
in the DSM-IV alcohol dependence and abuse diagnoses,
there are 211 - 1 = 2,047 different subsets of interest
(note that the empty subset is excluded). Within each
subset, the total number of criteria required to be en-
dorsed can also be varied from one up to the total num-
ber of items in the subset. For instance, within DSM-IV
three out of seven of the dependence criteria are re-
quired to be diagnosed with alcohol dependence. How-
ever, the threshold of three could easily be lowered to
two or raised to four. In DSM-5 American Psychiatric
Association (2013), which defines AUD as a unitary con-
struct (jettisoning the abuse/dependence distinction in
DSM-IV), the diagnostic threshold is two of eleven cri-
terion but alternative thresholds (1/11, 2/11, …11/11)
could be considered. The present investigation looks at
all possible thresholds for each of the criterion sets vary-
ing in size from 1 to 11, the total number of which is
provided in Table 3. A flowchart of the steps in the
optimization procedure is shown in Fig. 1.
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Results
For each of the 11,264 subsets seen in Table 3,
C(AUD1, AxI), C(AUD1, AxII), and P(AUD2|AUD1)
are ranked from smallest to largest and a rank-based
inverse normal transformation is performed (e.g., a
percentile based on the ranks is computed and the
corresponding z-score is computed), resulting in
Z(AUD1,AxI), Z(AUD1,AxII), and ZP(AUD2|AUD1), respect-
ively. Each of the subsets is then scored based on
the formula
Table 3 Number of criterion sets by set size and threshold
# Subsets by Threshold
# Criteria 1 2 3 4 5 6 7 8 9 10 11 Total
1 11 11
2 55 55 110
3 165 165 165 495
4 330 330 330 330 1,320
5 462 462 462 462 462 2,310
6 462 462 462 462 462 462 2,772
7 330 330 330 330 330 330 330 2,310
8 165 165 165 165 165 165 165 165 1,320
9 55 55 55 55 55 55 55 55 55 495
10 11 11 11 11 11 11 11 11 11 11 110
11 1 1 1 1 1 1 1 1 1 1 1 11
Total 2,047 2,036 1,981 1,816 1,486 1,024 562 232 67 12 1 11,264
Fig. 1 Flowchart of optimization procedure
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S ¼ α1ZP AUD2jAUD1ð Þ
þ α2 :5Z AUD1;AxIð Þ þ :5Z AUD1;AxIIð Þ
  ð3Þ
where α1 + α2 = 1. Furthermore, α1 (and by the require-
ment that α1 and α2 sum to one, α2 as well) was varied
from 0 to 1 in steps of .10. The criterion set and thresh-
old that resulted in the largest value of S is chosen as
the optimal decision rule for the specific level of α.
Internal validation
Given that all possible subsets are investigated, the
current optimization procedure had the same faults from
which most optimization procedures suffer. Namely, the
results are extremely susceptible to capitalization on
chance variation. To protect against this, a type of k-fold
cross validation was conducted. The original dataset of
n = 15,773 was randomly divided into five smaller data
sets (D1, D2, D3, D4, and D5) with sample sizes n1 =
3,154, n2 = 3,154, n3 = 3,155, n4 = 3,155, and n5 = 3,155,
respectively. The optimization procedure was conducted
on each of the five data sets at each of the eleven α
combinations, resulting in 55 potential solutions; results
are provided in Table 4.
The interpretation of the table is as follows. The first
five rows provide the current DSM-IV diagnosis for alco-
hol dependence as a reference. For these solutions, the α1
and α2 weights are irrelevant. P(AUD1) is the prevalence
of the diagnosis at Wave 1, while P(AUD2|AUD1) is the
persistence of the diagnosis. T refers to the threshold of
the number of criteria that must be endorsed from the
specific set – which is indicated by an “x” in the appropri-
ate column – for a diagnosis to be made. For instance, the
first row of D1 (sixth overall) is the optimal solution for
the four α combinations (α1, α2) = (1.0, .0), (.9, .1), (.8, .2),
(.7, .3). The prevalence of diagnosis is 7.4 %, while the per-
sistence of diagnosing at Wave 2 conditioned on diagnosis
at Wave 1 is 46.4 %. The optimal diagnosis rule at these
levels of α1 and α2 is endorsing two items out of the six
criterion set: Tolerance, Cutdown, Larger/Longer, Time-
Drinking, Withdrawal, Fight/Trouble.
A potentially complicating issue is that while the same
solution appears several times within a data set (for
Table 4 Optimal rules across replication data sets
Data α1 α2 P(AD1) P(AD2|AD1) T 1 2 3 4 5 6 7 8 9 10 11
D1 DSM-IV DSM-IV .042 .386 3 x x x x x x x
D2 DSM-IV DSM-IV .041 .453 3 x x x x x x x
D3 DSM-IV DSM-IV .039 .367 3 x x x x x x x
D4 DSM-IV DSM-IV .042 .376 3 x x x x x x x
D5 DSM-IV DSM-IV .031 .430 3 x x x x x x x
D1 1.0 – .7 .0 – .3 .074 .464 2 x x x x x x
.6 – .3 .4 – .7 .052 .387 3 x x x x x x x x
.2 – .0 .8 – 1.0 .054 .379 3 x x x x x x x x x
D2 1.0 – .8 .0 – .2 .090 .519 2 x x x x x x x x x
.7 .3 .032 .461 3 x x x x x x x x x
.6 – .5 .4 – .5 .040 .448 2 x x x x x x
.4 – .3 .6 – .7 .041 .445 2 x x x x x x x
.2 – .0 .8 – 1.0 .029 .391 3 x x x x x x
D3 1.0 – .6 .0 – .4 .021 .462 3 x x x x x
.5 .5 .041 .400 2 x x x x x x x
.4 .6 .058 .348 1 x x x x
.3 – .0 .7 – 1.0 .058 .339 1 x x x
D4 1.0 – .8 .0 – .2 .117 .473 1 x x x x x x
.7 – .0 .3 – 1.0 .063 .415 2 x x x x x x x
D5 1.0 .0 .117 .462 1 x x x x x x
.9 – .5 .1 – .5 .031 .443 2 x x x x x
.0 – .4 .6 – 1.0 .028 .425 2 x x x X x
Votes .51 .67 .49 .29 .62 .75 .98 .82 .29 .15 .60
α1 = weight for persistence; α2 = weight for comorbidity
AD DSM-IV alcohol dependence, T threshold
1 = Tolerance; 2 = Cut Down; 3 = Larger/Longer; 4 = Give Up; 5 = Time Drinking; 6 = Continue; 7 =Withdrawal; 8 = Home/Job; 9 = Hazardous Use;
10 = Legal; 11 = Fight/Trouble
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instance, the optimal solutions for D1 when α1 = 1.0,
α1 = .9, α1 = .8, and α1 = .7 are identical), no unique
solution appears in more than one data set. To choose a
final solution, one has to evaluate the response patterns ob-
served across all five data sets in a systematic fashion.
Often, for predictive modeling, there are several approaches
that could be used. Here, we consider two: (a) cross-
validation and (b) consensus.
Cross-validation Hastie et al. (2001) proceeds by com-
paring the performance of each of the optimal rules
found for all of the pairs of weights (α1, α2) to each of
the subsets of data that were created for the cross-
validation. Table 5 provides the rank, in terms of per-
centage) for each of the rules for every data set. For in-
stance, for the first row of Table 5, the rule of endorsing
two items out of the six item subset of Tolerance, Cut
Down, Larger/Longer, Time Drinking, Withdrawal, and
Fight/Trouble corresponded to the optimal rule for D1
when α1 ranged from .7 to 1 and α2 ranged from .3 to 0,
indicating that more weight is given to persistence and
less weight is given to comorbidity. This particular rule
works well for D5 and D4, appearing in the top 3.4 %
and 9.6 % (recall lower is better) of solutions, respect-
ively. However, worse performance is observed for D2
and D3, with the percentiles being 24.1 % and 38.8 %, re-
spectively. To score each of the rules that were found,
we used the maximum percentile; consequently, the
“score” for this rule would be 38.8 %. Then, best
solutions can be found by a simple min-max procedure
(see Brusco & Steinley, 2014, for a common implemen-
tation of such a rule), where the final rule chosen is the
one that minimizes the maximum percentile ranking
(e.g., the rule that does the least worst is chosen).
Inspecting Table 5, we see that endorsing 2 out of 9
items (Tolerance, Cut Down, Larger/Longer, Give Up,
Time Drinking, Continue, Withdrawal, Hazardous Use,
Fight/Trouble) is the best rule, with a maximum of
15.8 % when applied to the four validation data sets.
Alternatively, instead of choosing a rule based on spe-
cific weightings of persistence and comorbidity, one
could derive a natural “consensus” group of criteria
among a given set (see Steinley, 2008, for using consen-
sus to determine most similar observations), with each
appearing in optimal solutions a minimum percentage of
the time. The importance of individual criteria can be
determined by the proportion of times that they appear
in each of the 55 solutions, provided in the final row of
Table 4 (i.e. “Votes”). The order of importance (with per-
cent of times in the optimal solution in parentheses) is:
Withdrawal (98 %), Home/Job (82 %), Continue (75 %),
Cut Down (67 %), Time Drinking (62 %), Fight/Trouble
(60 %), Tolerance (51 %), Larger/Longer (49 %), Give Up
(29 %), Hazardous Use (29 %), and Legal (15 %). If we
chose 60 % as the cutoff for consensus that is considered
markedly above chance we would retain six criteria.
Following the guidelines mentioned in the introduction
Table 5 Performance of rules across random subsets
Rule α1 α2 D1 D2 D3 D4 D5 Maximum percentile
D1 1.0 – .7 .0 - .3 – 24.1 38.8 9.6 3.4 38.8
.6 – .3 .4 - .7 – 21.6 35.5 8.5 12.5 35.5
.2 – .0 .8 – 1.0 – 20.9 31.6 10.1 11.1 31.6
D2 1.0 – .8 .0 - .2 15.8 – 14.0 9.1 4.4 15.8
.7 .3 19.8 – 51.2 24.9 28.4 51.2
.6 – .5 .4 - .5 31.0 – 39.6 14.1 1.6 39.6
.4 – .3 .6 - .7 32.2 – 35.6 12.6 1.6 35.6
.2 – .0 .8 – 1.0 32.7 – 19.5 30.7 41.0 41.0
D3 1.0 – .6 .0 - .4 28.6 38.5 – 58.6 28.3 58.6
.5 .5 43.0 13.0 – 32.3 24.8 43.0
.4 .6 19.7 17.7 – 10.7 17.6 19.7
.3 – .0 .7 – 1.0 18.4 19.7 – 10.9 16.4 19.7
D4 1.0 – .8 .0 - .2 20.0 27.2 10.7 – 7.6 27.2
.7 – .0 .3 – 1.0 9.6 13.4 25.9 – 6.8 25.9
D5 1.0 .0 29.3 32.4 13.0 14.0 – 32.4
.9 – .5 .1 - .5 27.9 7.0 43.9 14.1 – 43.9
.0 – .4 .6 – 1.0 39 18.8 64.3 21.2 – 64.3
DSM-IV NA NA 11.9 12.7 42.3 9.5 14.2 42.3
Consensus NA NA 18.4 11.4 15.4 8.8 25.7 25.7
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warning against allowing single-criterion diagnosis, the
obvious threshold would be endorsing two items out of
the six item set [Withdrawal, Home/Job, Continue, Cut
Down, Time Drinking, Fight/Trouble]. This leads to an
overall solution that does not appear in any of the individ-
ual optimizations; however, it benefits from not being tied
directly to a specific weighting of comorbidity and persist-
ence, rather, it is “nominated” from the set of all solutions
that were found to be optimal.
External validation
To determine which internal validation procedure led to
a solution that performed best, both were compared on
a set of external variables that are thought to be corre-
lates with alcohol diagnosis. The variables used were a
set of variables assessed at Wave 2 by the SF-12-V2
health survey (Ware et al., 2002), where larger scores in-
dicate healthier individuals. In addition to general health
variables, three alcohol consumption variables from the
second wave of measurement were examined (DSM-5
AUD craving, volume of ethanol consumption, and
number of times an individual exceeded 4+/5+ drinks).
Finally, a series of anxiety and mood disorders were also
examined for significant differences (major depression,
dysthymia, hypomania, panic disorder, social phobia,
specific phobia, and generalized anxiety). All external
validators were tested via planned comparisons that took
into account sample weights to insure the results were
generalizable to the broader population.
Of the two approaches, only the consensus approach
identified differences on the external variables; as such,
presentation of the results for the solution identified via
cross-validation is omitted. Table 6 shows the 2 × 2
cross-classification table comparing those who diagnosis
under the existing DSM-IV schema for alcohol depend-
ence (3 of 7 criteria) and those who diagnose under the
consensus method (2 of 6 criteria, which included both
abuse and dependence criteria). Five hundred thirty-six
individuals diagnose under both approaches, while 145
diagnose under consensus only and 189 diagnose under
DSM-IV only.
To assess whether there were any significant differ-
ences between the individuals in these three subgroups
(Consensus Only, DSM-IV Only, and Both) on the set of
external validators, planned comparisons were con-
ducted (see Table 7). Table 7 consists of three primary
comparisons: Consensus versus DSM-IV; Consensus
versus Both; DSM-IV versus Both. Each of these com-
parisons is discussed in turn.
Consensus (only) vs. DSM-IV (only)
This comparison is comparing the individuals in the off-
diagonal cells of Table 6 (e.g., the 189 DSM-IV diagnoses
and the 145 Consensus diagnoses). The comparisons of
the individuals who only diagnose under one of the two
rules help assess whether the Consensus classification is
largely redundant with the DSM-IV classification. These
comparisons correspond to the first three columns in
Table 7, where it is seen that there are two significant
differences. Specifically, the individuals in the Consensus
only diagnosis had higher amounts of ethanol consump-
tion (t = 3.03, p < .01).
Consensus (only) vs. Both
This comparison is assessing whether adding those that
diagnose under the Consensus only model dilute the
severity of the individuals in the more extreme “Both”
category. While the Consensus only group has lower
levels of ethanol consumption (t = -2.22, p = .03), they
experience decreased vitality (t = -2.45, p = .04), in-
creased craving (t = 5.03, p < .01), and more instances
of consuming five or more drinks (t = 5.65, p < .01).
DSM-IV(only) vs. Both
This comparison is assessing whether removing individ-
uals who only diagnose under the DSM-IV scheme
would reduce the severity of the individuals in the more
extreme “Both” category. In this case, it is found that for
many of the external validators the DSM-IV only group
has better functioning, drinks less alcohol, and has fewer
associated personality disorders. The only variables that
exhibit more severity for the DSM-IV group are craving
(t = 6.55, p < .01) and more instances of consuming five
or more drinks (t = 5.24, p < .01).
Discussion
The basic approach to clinical diagnosis has remained
relatively unchanged for over 100 years. However, we
present an alternative computational approach that em-
pirically derives optimal criterion sets and thresholds for
diagnosis that makes use of extant data. This approach
is in line with previously proposed standards for evaluat-
ing diagnostic interviews (e.g. Spitzer, 1983) by making
fuller use of a broad set of existing data, but goes a step
further by also using modern computational advances to
provide objective assessments of all possible combinations
of diagnostic criteria based on a set of user-selected valid-
ity measures. Similarly, in line with recent criticisms re-
garding content overlap and super-/sub-additivity of
criterion information (Lane & Sher, 2014; Martin et al.,
2014) the current approach implicitly adjusts for such
Table 6 Cross-classification of DSM-IV diagnosis and consensus
diagnosis
DSM-IV – Yes DSM-IV – No
Consensus – Yes 536 (Both) 145 (Consensus Only)
Consensus - No 189 (DSM-IV Only) 14906 (No Both)
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combinations in its pruning of criteria that do not add
additional diagnostic information.
Our application of this approach to AUD using its
chronicity and comorbidity with other disorders as valid-
ity measures on which to find optimal solutions pro-
duced a diagnostic criterion set and threshold limit for
diagnosis that was considerably more parsimonious (6
versus 11 criteria) and efficient at classifying those with
associated alcohol problems (Table 7). Reducing the size
of the criterion set without loss of precision has clear
utility in reducing assessment burden, both on re-
searchers conducting empirical studies and on clinicians
treating patients. Furthermore, we observed that diagno-
sis as determined by our optimal solution contains indi-
viduals with more severe alcohol consumption and
mental and physical health problems compared to those
who only diagnose with DSM-IV alcohol dependence.
Using our optimal solution as the standard, these indi-
viduals may be considered falsely diagnosed “diagnostic
impostors” (Langenbucher et al., 1996) under the DSM-
IV algorithm given that they were diagnosed but had sig-
nificantly less impairment than those diagnosed under
both algorithms. This suggests that the optimal algo-
rithm derived by our analyses would result in fewer
Type 2 errors, assuming our external validation variables
did represent constructs with theoretically positively
overlapping content with the underlying disorder.
While this approach represents a significant advance-
ment in determining optimal criterion sets for clinical
diagnosis, the specific example we present represents
only a first step and proof of concept of more tailored
approaches that can be utilized. In the current example
we made assumptions about the weightings of the differ-
ent Axis II clusters and the equal weighting of Axis I
and Axis II disorders in estimating optimal alpha param-
eters. We constrained these in the current example due
to the exponential increase in permutations and compu-
tation time that would result in freeing them, though fu-
ture extensions could consider this. Similarly, in the
current application we used a binary threshold rule for
diagnosis, as in DSM-IV, though the model could be ex-
panded to incorporate a graded response scale as in
DSM-5. Lastly, and perhaps most significantly from a
substantive perspective, the current approach is agnostic
as to the validity criteria that it is given to find an opti-
mal solution. We selected two measures (chronicity and
comorbidity) for their clinical and historical relevance.
However, others may disagree and consider different
Table 7 Results of external validation
Variable Consensus only vs. DSM-IV only Consensus only vs. both DSM-IV only vs. both
Diff. t p Diff. t p Diff. t p
Phys. Hlth. −.89 −.77 .44 .23 .23 .82 1.11 .97 .26
Ment. Hlth. −2.21 −1.92 .06 .66 .57 .57 2.86 2.91 <.01
Phys. Health (Sub) −.62 −.55 .58 .64 .68 .50 1.26 1.39 .17
Role Phys. −1.57 −1.29 .20 −.64 −.61 .54 .92 .90 .37
Bodily Pain −.66 −.41 .68 1.42 1.10 .27 2.08 1.58 .12
Gen. Hlth. −1.87 −1.40 .17 .70 .60 .55 2.57 2.17 .03
Vitality −2.58 −1.85 .07 −2.45 −2.07 .04 .12 .12 .90
Social −2.10 −1.88 .06 2.38 1.94 .06 4.49 4.27 <.01
Role Emotional −1.30 −1.00 .32 2.13 1.81 .08 3.44 2.86 <.01
Ment. Hlth. (Sub) −1.85 −1.41 .16 -.24 -.20 .84 1.60 1.59 .12
Craving −.03 -.66 .51 .25 5.03 <.01 .28 6.55 <.01
Ethanol Consump. .69 3.03 <.01 −1.12 −2.22 .03 −1.80 −3.81 <.01
Major Depression .03 .80 .43 −.04 −1.03 .31 −.07 −2.18 .03
Dysthymia .03 1.45 .15 .01 .35 .73 −.03 −1.73 .09
Hypomania .03 1.72 .09 .00 .05 .95 −.03 −2.92 <.01
Panic Disorder .03 1.25 .21 .00 −.14 .89 −.03 −1.99 .05
Social Phobia .00 -.06 .95 .00 .11 .91 .01 .21 .84
Specific Phobia .06 1.48 .14 .00 −.10 .92 −.07 −2.16 .03
Gen. Anxiety .01 .31 .76 −.03 −1.07 .28 −.03 −1.67 .10
5+ Drinks .37 .92 .36 2.01 5.65 <.01 1.65 5.24 <.01
All validation variables were assessed at Wave 2. The validators major depression, dysthymia, hypomania, panic disorder, social phobia, specific phobia, and
generalized anxiety are all from Wave 2, whereas the same variables from Wave 1 were used as part of the comorbidity measure. The bolded numbers in the
table indicate significant differences
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measures to be more diagnostic and objective (e.g., bio-
markers). The same approach can be used to identify op-
timal solutions with different measures and with more
or fewer measures. We do find it of interest that the
consensus ranking of criteria placed both hazardous use
and legal problems last among candidate criteria. The
problems with legal problems has been increasingly rec-
ognized in recent years and, in fact, was the only criter-
ion from DSM-IV not retained in DSM-5. Although
hazardous use was retained in DSM-5, we Martin et al.
(2011a) had advocated against its inclusion in DSM-5 on
conceptual grounds. That is, the approach we have
employed here appears not only useful for identifying ef-
ficient criteria sets and algorithms but also for identify-
ing potentially problematic criteria.
Limitations
One potential limitation is that the optimized rule is
drawn from a pool of 11 items, while the DSM-IV de-
pendence criteria is drawn from a fixed pool of 7 items,
allowing the greater capitalization on chance by the Opti-
mal Approach. This potential shortcoming is mitigated by
relying on the Consensus Approach to determining the
final rule instead of any one analysis. Further, it highlights
both the dangers of the bifurcation of items as operation-
alized in DSM-IV and, due to the irrelevance of some
items as related to the optimization criteria. As mentioned
above, future research will extend this approach to the
DSM-5 criteria set (which includes craving) due to the
likely fact that pooling all items into one group to obtain a
resultant sum score introduces unneeded noise into the
diagnostic algorithm. Indeed, we would have employed
the DSM-5 criteria set in the current series of analyses
had we had a sufficiently large sample assessing craving at
more than one time point but, unfortunately, NESARC
only assessed craving at Wave 2.
Conclusion
We provide a worked example of how optimal sets of
diagnostic criteria can be computationally derived from
the existing AUD criterion set using multiple external
validity measures that are broadly accepted as robust
indicators of disorder. Given the increasing availability
of large-scale, population-based epidemiological stud-
ies, similar procedures can be applied to criterion sets
for a wide array of other disorders and can be mobi-
lized to improve efficiency and precision within both
research and healthcare domains. Such steps represent
advances that a number of researchers and clinicians
alike have been advocating for years and, at the very
least, can complement the expert panels and literature
reviews when revising diagnostic criterion sets and
diagnosis thresholds.
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